Skip to main content
Top
Published in: BMC Gastroenterology 1/2019

Open Access 01-12-2019 | Esophageal Varices | Research article

The magnitude and correlates of esophageal Varices among newly diagnosed cirrhotic patients undergoing screening fibre optic endoscope before incident bleeding in North-Western Tanzania; a cross-sectional study

Authors: Daniel W. Gunda, Semvua B. Kilonzo, Zakhia Mamballah, Paulina M. Manyiri, David C. Majinge, Hyasinta Jaka, Benson R. Kidenya, Humphrey D. Mazigo

Published in: BMC Gastroenterology | Issue 1/2019

Login to get access

Abstract

Background

Bleeding esophageal varices is a deadly complication of liver cirrhosis. Guidelines recommend an early diagnosis of esophageal varices before incident bleeding by screening all patients diagnosed with liver cirrhosis. Though it has been reported elsewhere that the presence of esophageal varices varies widely among cirrhotic patients this has not been assessed in Tanzania since endoscopy is not readily available for routine use in our setting. This study was designed to determine the prevalence of esophageal varices and assess the utility of clinical parameters in predicting the presence of varices among cirrhotic patients in northwestern Tanzania.

Methods

A cross-sectional analysis of adult patients with liver cirrhosis was done at Bugando Medical Centre. Demographic, clinical, laboratory and endoscopic data were collected and analyzed using STATA 13. The presence of esophageal varices was detected using endoscopic examination and associated factors were assessed by logistic regression. The predictive value of clinical predictors was also assessed by calculating sensitivity and specificity.

Results

A total of 223 patients were enrolled, where 88 (39.5%; 95%CI: 33.0–45.9) had esophageal varices. The varices were independently associated with increased age (OR: 1.02; 95%CI: 1.0–1.04; p = 0.030); increased splenic diameter (OR:1.3; 95%CI:1.2–1.5; p <  0.001), increased portal vein diameter (OR:1.2; 95%CI: 1.07–1.4; p = 0.003), having ascites (OR: 3.0; 95%CI: 1.01–8.7; p = 0.046), and advanced liver disease (OR: 2.9; 95%CI: 1.3–6.7; p = 0.008). PSDR least performed in predicting varices, (AUC: 0.382; 95%CI: 0.304–0.459; cutoff: < 640; Sensitivity: 58.0%; 95%CI: 46.9–68.4; specificity: 57.0%; 95%CI: 48.2–65.5). SPD had better prediction; (AUC: 0.713; 95%CI: 0.646–0.781; cut off: > 15.2 cm; sensitivity: 65.9%; (95% CI: 55–75.7 and specificity:65.2%; 95%CI: 56.5–73.2), followed by PVD, (AUC: 0.6392; 95%CI: 0.566–0.712;cutoff: > 1.45 cm; sensitivity: 62.5%; 95CI: 51.5–72.6; specificity: 61.5%; 95%CI: 52.7–69.7).

Conclusion

Esophageal varices were prevalent among cirrhotic patients, most of which were at risk of bleeding. The non-invasive prediction of varices was not strong enough to replace endoscopic diagnosis. However, the predictors in this study can potentially assist in the selection of patients at high risk of having varices and prioritize them for endoscopic screening and appropriate management.
Literature
1.
go back to reference de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001;5(3):645–63.CrossRef de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001;5(3):645–63.CrossRef
2.
go back to reference D'Amico G, Morabito A. Noninvasive markers of esophageal varices: another round, not the last. Hepatology. 2004;39(1):30–4.CrossRef D'Amico G, Morabito A. Noninvasive markers of esophageal varices: another round, not the last. Hepatology. 2004;39(1):30–4.CrossRef
3.
go back to reference Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80(4):800–9.CrossRef Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology. 1981;80(4):800–9.CrossRef
4.
go back to reference D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217–31.CrossRef D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217–31.CrossRef
5.
go back to reference D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38(3):599–612.CrossRef D'Amico G, De Franchis R. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology. 2003;38(3):599–612.CrossRef
6.
go back to reference Moledina SM, Komba E. Risk factors for mortality among patients admitted with upper gastrointestinal bleeding at a tertiary hospital: a prospective cohort study. BMC Gastroenterol. 2017;17(1):165.CrossRef Moledina SM, Komba E. Risk factors for mortality among patients admitted with upper gastrointestinal bleeding at a tertiary hospital: a prospective cohort study. BMC Gastroenterol. 2017;17(1):165.CrossRef
7.
go back to reference Spiegel BM, et al. Endoscopic screening for esophageal varices in cirrhosis: is it ever cost-effective? Hepatology. 2003;37(2):366–77.CrossRef Spiegel BM, et al. Endoscopic screening for esophageal varices in cirrhosis: is it ever cost-effective? Hepatology. 2003;37(2):366–77.CrossRef
8.
go back to reference Aoki N, et al. Decision analysis of prophylactic treatment for patients with high-risk esophageal varices. Gastrointest Endosc. 2000;52(6):707–14.CrossRef Aoki N, et al. Decision analysis of prophylactic treatment for patients with high-risk esophageal varices. Gastrointest Endosc. 2000;52(6):707–14.CrossRef
9.
go back to reference Garcia-Tsao G, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922–38.CrossRef Garcia-Tsao G, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46(3):922–38.CrossRef
10.
go back to reference Di Pascoli L, et al. Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices. World J Gastroenterol. 2014;20(30):10464–9.CrossRef Di Pascoli L, et al. Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices. World J Gastroenterol. 2014;20(30):10464–9.CrossRef
11.
go back to reference Zaman A, et al. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med. 2001;161(21):2564–70.CrossRef Zaman A, et al. Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med. 2001;161(21):2564–70.CrossRef
12.
go back to reference Zein CO, Lindor KD, Angulo P. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. Hepatology. 2004;39(1):204–10.CrossRef Zein CO, Lindor KD, Angulo P. Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis. Hepatology. 2004;39(1):204–10.CrossRef
13.
go back to reference Madhotra R, et al. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2002;34(1):81–5.CrossRef Madhotra R, et al. Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol. 2002;34(1):81–5.CrossRef
14.
go back to reference Giannini E, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003;52(8):1200–5.CrossRef Giannini E, et al. Platelet count/spleen diameter ratio: proposal and validation of a non-invasive parameter to predict the presence of oesophageal varices in patients with liver cirrhosis. Gut. 2003;52(8):1200–5.CrossRef
15.
go back to reference Ying L, et al. Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis. Dig Dis Sci. 2012;57(6):1672–81.CrossRef Ying L, et al. Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis. Dig Dis Sci. 2012;57(6):1672–81.CrossRef
16.
go back to reference Abby Philips C, Sahney A. Oesophageal and gastric varices: historical aspects,classification, and grading: everything in one place. Gastroenterol Rep (Oxf). 2016;4(3):186–95.CrossRef Abby Philips C, Sahney A. Oesophageal and gastric varices: historical aspects,classification, and grading: everything in one place. Gastroenterol Rep (Oxf). 2016;4(3):186–95.CrossRef
17.
go back to reference Cherian JV, et al. Non-invasive predictors of esophageal varices. Saudi J Gastroenterol. 2011;17(1):64–8.CrossRef Cherian JV, et al. Non-invasive predictors of esophageal varices. Saudi J Gastroenterol. 2011;17(1):64–8.CrossRef
18.
go back to reference Hong WD, et al. Predictors of esophageal varices in patients with HBV-related cirrhosis: a retrospective study. BMC Gastroenterol. 2009;9:11.CrossRef Hong WD, et al. Predictors of esophageal varices in patients with HBV-related cirrhosis: a retrospective study. BMC Gastroenterol. 2009;9:11.CrossRef
19.
go back to reference Nada L, et al. Noninvasive predictors of presence and grade of esophageal varices in viral cirrhotic patients. Pan Afr Med J. 2015;20:145.CrossRef Nada L, et al. Noninvasive predictors of presence and grade of esophageal varices in viral cirrhotic patients. Pan Afr Med J. 2015;20:145.CrossRef
20.
go back to reference Fagundes ED, et al. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome. J Pediatr Gastroenterol Nutr. 2008;46(2):178–83.CrossRef Fagundes ED, et al. Clinical and laboratory predictors of esophageal varices in children and adolescents with portal hypertension syndrome. J Pediatr Gastroenterol Nutr. 2008;46(2):178–83.CrossRef
21.
go back to reference Planas R, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol. 2004;40(5):823–30.CrossRef Planas R, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol. 2004;40(5):823–30.CrossRef
22.
go back to reference Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36.CrossRef Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36.CrossRef
23.
go back to reference Levy C, et al. Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2007;5(7):803–8.CrossRef Levy C, et al. Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2007;5(7):803–8.CrossRef
24.
go back to reference Zaman A, et al. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol. 1999;94(11):3292–6.CrossRef Zaman A, et al. Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol. 1999;94(11):3292–6.CrossRef
25.
go back to reference Merli M, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38(3):266–72.CrossRef Merli M, et al. Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol. 2003;38(3):266–72.CrossRef
26.
go back to reference Bosch J, et al. The management of portal hypertension: rational basis, available treatments, and future options. J Hepatol. 2008;48(Suppl 1):S68–92.CrossRef Bosch J, et al. The management of portal hypertension: rational basis, available treatments, and future options. J Hepatol. 2008;48(Suppl 1):S68–92.CrossRef
27.
go back to reference Poynard T, et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian multicenter study group. N Engl J Med. 1991;324(22):1532–8.CrossRef Poynard T, et al. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian multicenter study group. N Engl J Med. 1991;324(22):1532–8.CrossRef
28.
go back to reference Kraja B, et al. Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients. World J Gastroenterol. 2017;23(26):4806–14.CrossRef Kraja B, et al. Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients. World J Gastroenterol. 2017;23(26):4806–14.CrossRef
29.
go back to reference Garcia-Tsao G, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol. 2007;102(9):2086–102.CrossRef Garcia-Tsao G, et al. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol. 2007;102(9):2086–102.CrossRef
30.
go back to reference Tripathi D, et al. U.K. guidelines on the management of variceal hemorrhage in cirrhotic patients. Gut. 2015;64(11):1680–704.CrossRef Tripathi D, et al. U.K. guidelines on the management of variceal hemorrhage in cirrhotic patients. Gut. 2015;64(11):1680–704.CrossRef
31.
32.
go back to reference Sharma SK, Aggarwal R. Prediction of large esophageal varices in patients with cirrhosis of the liver using clinical, laboratory and imaging parameters. J Gastroenterol Hepatol. 2007;22(11):1909–15.CrossRef Sharma SK, Aggarwal R. Prediction of large esophageal varices in patients with cirrhosis of the liver using clinical, laboratory and imaging parameters. J Gastroenterol Hepatol. 2007;22(11):1909–15.CrossRef
33.
go back to reference Kovalak M, et al. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc. 2007;65(1):82–8.CrossRef Kovalak M, et al. Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database. Gastrointest Endosc. 2007;65(1):82–8.CrossRef
34.
go back to reference Colli A, et al. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev. 2017;4:CD008759.PubMed Colli A, et al. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev. 2017;4:CD008759.PubMed
35.
go back to reference Schepis F, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology. 2001;33(2):333–8.CrossRef Schepis F, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology. 2001;33(2):333–8.CrossRef
36.
go back to reference Thomopoulos KC, et al. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis. 2003;35(7):473–8.CrossRef Thomopoulos KC, et al. Non-invasive predictors of the presence of large oesophageal varices in patients with cirrhosis. Dig Liver Dis. 2003;35(7):473–8.CrossRef
37.
go back to reference Jamil Z, Malik M, Durrani AA. Platelet count to splenic diameter ratio and other noninvasive markers as predictors of esophageal varices in patients with liver cirrhosis. Turk J Gastroenterol. 2017;28(5):347–52.CrossRef Jamil Z, Malik M, Durrani AA. Platelet count to splenic diameter ratio and other noninvasive markers as predictors of esophageal varices in patients with liver cirrhosis. Turk J Gastroenterol. 2017;28(5):347–52.CrossRef
38.
go back to reference Bhattarai S, et al. Non-invasive predictors of gastro-Oesophageal Varices. JNMA J Nepal Med Assoc. 2017;56(207):298–303.CrossRef Bhattarai S, et al. Non-invasive predictors of gastro-Oesophageal Varices. JNMA J Nepal Med Assoc. 2017;56(207):298–303.CrossRef
39.
go back to reference Ng FH, et al. Prediction of oesophagogastric varices in patients with liver cirrhosis. J Gastroenterol Hepatol. 1999;14(8):785–90.CrossRef Ng FH, et al. Prediction of oesophagogastric varices in patients with liver cirrhosis. J Gastroenterol Hepatol. 1999;14(8):785–90.CrossRef
40.
go back to reference Khan H. A marker of esophageal varices in chronic liver disease due to hepatitis B and C. Rawal Med J. 2009;34(1):4. Khan H. A marker of esophageal varices in chronic liver disease due to hepatitis B and C. Rawal Med J. 2009;34(1):4.
Metadata
Title
The magnitude and correlates of esophageal Varices among newly diagnosed cirrhotic patients undergoing screening fibre optic endoscope before incident bleeding in North-Western Tanzania; a cross-sectional study
Authors
Daniel W. Gunda
Semvua B. Kilonzo
Zakhia Mamballah
Paulina M. Manyiri
David C. Majinge
Hyasinta Jaka
Benson R. Kidenya
Humphrey D. Mazigo
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2019
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-019-1123-9

Other articles of this Issue 1/2019

BMC Gastroenterology 1/2019 Go to the issue